Literature DB >> 10079270

Bone marrow-derived cells are required for the induction of a pulmonary inflammatory response mediated by CD40 ligation.

J A Wiley1, A G Harmsen.   

Abstract

The expression of inflammatory mediators by various cells following in vitro CD40 ligation is well known. However, knowledge of the role and interaction with these cells in the establishment and maintenance of in vivo immune-mediated inflammation is limited. In this report, a chimeric mouse model based on CD40 knockout and wild-type mice was used to assess the role of bone marrow (BM)-derived and non-BM-derived cells in a CD40-mediated pulmonary inflammation response. CD40+ BM-derived cells were required for initial cell recruitment, pulmonary edema, and weight loss associated with this response. The structural CD40+ non-BM-derived cells of the lung, such as fibroblasts, epithelial cells, and endothelial cells, could not by themselves establish any level of pulmonary inflammation. However, both the CD40+ BM-derived cells and the structural CD40+ non-BM-derived cells of the lung were required to maximize the level of pulmonary inflammation. Both B cells and T cells played a contributing role in macrophage recruitment and pulmonary edema but neither contributed to the inflammation-associated weight loss. These experiments indicate that CD40+ BM-derived cells were critical to the induction of pulmonary inflammation and that alveolar macrophages, B cells, and T cells contributed to selective aspects of the response.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10079270      PMCID: PMC1866430          DOI: 10.1016/S0002-9440(10)65339-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

Review 1.  The many roles of CD40 in cell-mediated inflammatory responses.

Authors:  R D Stout; J Suttles
Journal:  Immunol Today       Date:  1996-10

2.  Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization.

Authors:  R B Mendoza; M J Cantwell; T J Kipps
Journal:  J Immunol       Date:  1997-12-15       Impact factor: 5.422

3.  Alveolar macrophages in sarcoidosis coexpress high levels of CD86 (B7.2), CD40, and CD30L.

Authors:  L P Nicod; P Isler
Journal:  Am J Respir Cell Mol Biol       Date:  1997-07       Impact factor: 6.914

4.  Exogenous CD40 ligand induces a pulmonary inflammation response.

Authors:  J A Wiley; R Geha; A G Harmsen
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

5.  CD40 is a functional activation antigen and B7-independent T cell costimulatory molecule on normal human lung fibroblasts.

Authors:  G D Sempowski; P R Chess; R P Phipps
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

6.  CD40 mediated activation of gingival and periodontal ligament fibroblasts.

Authors:  G D Sempowski; P R Chess; A J Moretti; J Padilla; R P Phipps; T M Blieden
Journal:  J Periodontol       Date:  1997-03       Impact factor: 6.993

7.  Phenotyping and cytokine regulation of the BEAS-2B human bronchial epithelial cell: demonstration of inducible expression of the adhesion molecules VCAM-1 and ICAM-1.

Authors:  J Atsuta; S A Sterbinsky; J Plitt; L M Schwiebert; B S Bochner; R P Schleimer
Journal:  Am J Respir Cell Mol Biol       Date:  1997-11       Impact factor: 6.914

8.  CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells.

Authors:  J Déchanet; C Grosset; J L Taupin; P Merville; J Banchereau; J Ripoche; J F Moreau
Journal:  J Immunol       Date:  1997-12-01       Impact factor: 5.422

9.  Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice.

Authors:  C H Clegg; J T Rulffes; H S Haugen; I H Hoggatt; A Aruffo; S K Durham; A G Farr; D Hollenbaugh
Journal:  Int Immunol       Date:  1997-08       Impact factor: 4.823

Review 10.  Functions of CD40 and its ligand, gp39 (CD40L).

Authors:  J D Laman; E Claassen; R J Noelle
Journal:  Crit Rev Immunol       Date:  1996       Impact factor: 2.214

View more
  5 in total

1.  CD40 ligand enhances immunogenicity of vector-based vaccines in immunocompetent and CD4+ T cell deficient individuals.

Authors:  Matthew W Auten; Weitao Huang; Guixiang Dai; Alistair J Ramsay
Journal:  Vaccine       Date:  2012-02-18       Impact factor: 3.641

2.  Pathogenic role of B cells in anti-CD40-induced necroinflammatory liver disease.

Authors:  Kiminori Kimura; Hisataka Moriwaki; Masahito Nagaki; Masanao Saio; Yasunari Nakamoto; Makoto Naito; Kazuo Kuwata; Francis V Chisari
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

3.  Pneumocystis infection enhances antibody-mediated resistance to a subsequent influenza infection.

Authors:  James A Wiley; Allen G Harmsen
Journal:  J Immunol       Date:  2008-04-15       Impact factor: 5.422

Review 4.  State-of-the-Art of Nanodiagnostics and Nanotherapeutics against SARS-CoV-2.

Authors:  Mohammad Ali Derakhshan; Amir Amani; Reza Faridi-Majidi
Journal:  ACS Appl Mater Interfaces       Date:  2021-03-29       Impact factor: 9.229

5.  Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses.

Authors:  James A Wiley; Laura E Richert; Steve D Swain; Ann Harmsen; Dale L Barnard; Troy D Randall; Mark Jutila; Trevor Douglas; Chris Broomell; Mark Young; Allen Harmsen
Journal:  PLoS One       Date:  2009-09-23       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.